deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02107391

Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

Randomized, Open-label, Parallel-group, Multi-centre Phase II Clinical Trial of Active Cellular Immunotherapy With Preparation DCVAC/PCa in Combination With Hormone Therapy in Patients With Metastatic Prostate Cancer

Sponsor: SOTIO a.s.

Conditions Prostate Cancer
Interventions Dendritic Cells DCVAC/PCa Goserelin Acetate Leuprolide acetate
Updated 9 times since 2017 Last updated: May 23, 2017 Started: Mar 31, 2012 Primary completion: Dec 31, 2015 Completion: Jun 30, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02107391, this PHASE2 trial focuses on Prostate Cancer and remains completed. Sponsored by SOTIO a.s., it has been updated 9 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshotActive Not Recruiting~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshotCompleted~Nov 2021 – ~Sep 2023 · 22 months · monthly snapshotCompleted~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Sep 2023 — Jul 2024 [monthly]

    Completed PHASE2

  5. Nov 2021 — Sep 2023 [monthly]

    Completed PHASE2

▶ Show 4 earlier versions

  1. Jan 2021 — Nov 2021 [monthly]

    Completed PHASE2

  2. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  3. Jun 2017 — Jun 2018 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Jan 2017 — Jun 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • SOTIO a.s.
Data source: Sotio Biotech Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations